This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
MBChB MMedSc PhD
University of Auckland
Associate Investigators | Maurice Wilkins Centre
"Through the current Phase 1b study ...
"Through the current Phase 1b study in NSCLC and prior Phase 1 trials of demcizumab we have learned much about its safety and anti-tumor properties," said Mark McKeage, MBChB, MMedSc, Ph.D., FRACP, University of Auckland.
Editorial Team - Journal of Thoracic Disease
Local cancer drug approved for first clinical trial in United States and New Zealand | Maurice Wilkins Centre
Magna International Inc
LB Steel LLC
Dilworth Paxson LLP